Ulocuplumab
Ulocuplumab (BMS-936564) is a fully human anti-CXCR4 IgG4 antibody.Ulocplumab exhibits antitumor activity in acute myeloid leukemia (AML), non-Hodgkin's lymphoma (NHL), and multiple myeloma transplantation models.Ulocplumab inhibits the migration of chronic lymphocytic leukemia (CLL) cells under CXCR4 activation, induces apoptosis, and inhibits the growth and migration of cancer cells. Ulocplumab inhibits CXCL12-mediated chronic lymphocytic leukemia (CLL) cell migration in response to CXCR4 activation and induces apoptosis.)
Product Specifications
CAS Number
1375830-34-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
146.2 (kDa)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
CXCR | Apoptosis
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6054806 1.0 µg DNA
Tomm7 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details MVA81015-01 250 mg
2-[5-Methyl-3- (trifluoromethyl) -1H-pyrazol-1-yl]acetohydrazide
Sign In for Pricing
View Details